<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="11" ids="22586">Antioxidants</z:chebi> have been the focus of studies for developing neuroprotective agents to be used in the therapy for <z:hpo ids='HP_0001297'>stroke</z:hpo>, which is an <z:hpo ids='HP_0011009'>acute</z:hpo> and progressive <z:e sem="disease" ids="C0524851" disease_type="Disease or Syndrome" abbrv="">neurodegenerative disorder</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Medicago sativa (MS) has a long tradition of use as ayurvedic and homoeopathic medicine in central <z:mp ids='MP_0008912'>nervous</z:mp> system disorders </plain></SENT>
<SENT sid="2" pm="."><plain>The plant has been reported to have <z:chebi fb="11" ids="22586">antioxidant</z:chebi>, anti-inflammatory and <z:chebi fb="0" ids="35526">antidiabetic</z:chebi> effects </plain></SENT>
<SENT sid="3" pm="."><plain>Therefore, the present study was designed to investigate the neuroprotective effect of <z:chebi fb="43" ids="17790">methanol</z:chebi> extract of MS on <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and reperfusion-induced cerebral injury in mice </plain></SENT>
<SENT sid="4" pm="."><plain>Bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> (BCAO) for 15 min followed by 24-h reperfusion, resulted in significant elevation in <z:mpath ids='MPATH_124'>infarct</z:mpath> size, <z:chebi fb="1" ids="15318,17712">xanthine</z:chebi> oxidase (XO) activity, <z:chebi fb="1" ids="18421">superoxide</z:chebi> <z:chebi fb="5" ids="22563">anion</z:chebi> (O(•-) (2)) production and <z:chebi fb="0" ids="33202">thiobarbituric acid</z:chebi>-reactive substance (TBARS) levels, and significant <z:mpath ids='MPATH_63'>depletion</z:mpath> in endogenous <z:chebi fb="11" ids="22586">antioxidant</z:chebi> [reduced <z:chebi fb="0" ids="16856">glutathione</z:chebi> (GSH), <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (SOD) and total tissue sulfhydryl (T-SH) groups] systems in mice brain </plain></SENT>
<SENT sid="5" pm="."><plain>Further, BCAO led to impairment in short-term memory and motor coordination </plain></SENT>
<SENT sid="6" pm="."><plain>Pre-treatment with MS (100 or 200 mg kg(-1), p.o.) markedly reduced cerebral <z:mpath ids='MPATH_124'>infarct</z:mpath> size, XO, O(•-) (2) and TBARS levels, significantly restored GSH, SOD and T-SH levels and attenuated impairment in short-term memory and motor coordination </plain></SENT>
<SENT sid="7" pm="."><plain>In addition, MS directly scavenged free radicals generated against a stable radical 1,1-diphenyl-2-picrylhydrazyl and O(•-) (2) generated in <z:chebi fb="0" ids="8055">phenazine methosulphate</z:chebi>-<z:chebi fb="0" ids="13389">nicotinamide adenine dinucleotide</z:chebi> systems, and also inhibited XD/XO conversion and resultant O(•-) (2) production </plain></SENT>
<SENT sid="8" pm="."><plain>The data from this study suggest that treatment with MS enhances the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> defense against BCAO-induced global <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and exhibits neuroprotective activity </plain></SENT>
</text></document>